CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Quoin Pharmaceuticals' Potential Skin Disease Treatment Receives US Name Approval

RegulatoryapprovedPositive
AI Analysis

Summary

Quoin Pharmaceuticals received US name approval for a potential skin disease treatment. The approval represents a regulatory milestone in the drug development process.

Outcome Details

US name approval received

Importance:4/10
Sentiment:
0.60
regulatory approvaldermatologyQNRX
Related Companies

Read the original article

Published by yahoo_finance on June 23, 2026 12:58 PM

Read Original